Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens
Authors
Keywords
Linezolid, Epithelial Line Fluid, Oxazolidinone, Linezolid Resistance, Early Clinical Response
Journal
DRUGS
Volume 75, Issue 3, Pages 253-270
Publisher
Springer Nature
Online
2015-02-11
DOI
10.1007/s40265-015-0352-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tedizolid: A new oxazolidinone antimicrobial
- (2014) J. J. Kisgen et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Platelet Profile in Patients with Acute Bacterial Skin and Skin Structure Infections Receiving Tedizolid or Linezolid: Findings from the Phase 3 ESTABLISH Clinical Trials
- (2014) Thomas P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification and Characterization of Linezolid-Resistantcfr-Positive Staphylococcus aureus USA300 Isolates from a New York City Medical Center
- (2014) Jeffrey B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Tedizolid in Subjects with Renal or Hepatic Impairment
- (2014) S. Flanagan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tedizolid Population Pharmacokinetics, Exposure Response, and Target Attainment
- (2014) S. Flanagan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Linezolid update: Stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms
- (2014) Rodrigo E. Mendes et al. DRUG RESISTANCE UPDATES
- New pharmacological treatments for methicillin-resistantStaphylococcus aureusinfections
- (2014) Stuart L Burke et al. EXPERT OPINION ON PHARMACOTHERAPY
- In vitro antimicrobial activity of the novel oxazolidinone tedizolid and comparator agents against Staphylococcus aureus and linezolid-resistant Gram-positive pathogens: a multicentre study in China
- (2014) Hongbin Chen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial
- (2014) Gregory J Moran et al. LANCET INFECTIOUS DISEASES
- Single- and Multiple-Dose Pharmacokinetics and Absolute Bioavailability of Tedizolid
- (2014) Shawn Flanagan et al. PHARMACOTHERAPY
- Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone
- (2014) Gary Zurenko et al. Annals of Clinical Microbiology and Antimicrobials
- In Vitro,In Vivo, and Clinical Studies of Tedizolid To Assess the Potential for Peripheral or Central Monoamine Oxidase Interactions
- (2013) S. Flanagan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- FDA Guidance for ABSSSI Trials: Implications for Conducting and Interpreting Clinical Trials
- (2013) K. M. F. Itani et al. CLINICAL INFECTIOUS DISEASES
- Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen
- (2013) M. E. Stryjewski et al. CLINICAL INFECTIOUS DISEASES
- Tedizolid Phosphate for the Management of Acute Bacterial Skin and Skin Structure Infections: Safety Summary
- (2013) D. Das et al. CLINICAL INFECTIOUS DISEASES
- Methicillin-Resistant Staphylococcus aureus Therapy: Past, Present, and Future
- (2013) K. A. Rodvold et al. CLINICAL INFECTIOUS DISEASES
- Use of Pharmacokinetic/Pharmacodynamic Systems Analyses to Inform Dose Selection of Tedizolid Phosphate
- (2013) Thomas P. Lodise et al. CLINICAL INFECTIOUS DISEASES
- Tedizolid for the Management of Human Infections: In Vitro Characteristics
- (2013) Jeffrey B. Locke et al. CLINICAL INFECTIOUS DISEASES
- Tedizolid: A Novel Oxazolidinone for Gram-Positive Infections
- (2013) Robert C. Moellering CLINICAL INFECTIOUS DISEASES
- Characterization and monitoring of linezolid-resistant clinical isolates of Staphylococcus epidermidis in an intensive care unit 4 years after an outbreak of infection by cfr-mediated linezolid-resistant Staphylococcus aureus
- (2013) Elvira Baos et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Current and prospective treatments for multidrug-resistant gram-positive infections
- (2013) Jeffrey M Rybak et al. EXPERT OPINION ON PHARMACOTHERAPY
- Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections
- (2013) Philippe Prokocimer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug
- (2013) Shawn D. Flanagan et al. PHARMACOTHERAPY
- Activity of Tedizolid Phosphate (TR-701) in Murine Models of Infection with Penicillin-Resistant and Penicillin-Sensitive Streptococcus pneumoniae
- (2012) Sunghak Choi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections
- (2012) Philippe Prokocimer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers
- (2012) Seth T. Housman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Pharmacodynamics of the New Oxazolidinone Tedizolid Phosphate and Linezolid in a Neutropenic Murine Staphylococcus aureus Pneumonia Model
- (2012) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Efficacies of Human Simulated Exposures of Tedizolid and Linezolid against Staphylococcus aureus in the Murine Thigh Infection Model
- (2012) R. A. Keel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ComparativeIn VivoEfficacies of Epithelial Lining Fluid Exposures of Tedizolid, Linezolid, and Vancomycin for Methicillin-Resistant Staphylococcus aureus in a Mouse Pneumonia Model
- (2012) Pamela R. Tessier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent development of potent analogues of oxazolidinone antibacterial agents
- (2012) Katarzyna Michalska et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Tedizolid (TR-701): a new oxazolidinone with enhanced potency
- (2012) Zeina A. Kanafani et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers
- (2012) Martina Sahre et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The oxazolidinones: past, present, and future
- (2011) Karen Joy Shaw et al. Annals of the New York Academy of Sciences
- In VivoPharmacodynamics of Torezolid Phosphate (TR-701), a New Oxazolidinone Antibiotic, against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Strains in a Mouse Thigh Infection Model
- (2011) Arnold Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Granulocytes on the Antimicrobial Effect of Tedizolid in a Mouse Thigh Infection Model
- (2011) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MRSA: the first half century
- (2011) R. C. Moellering JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci
- (2011) I. Rodriguez-Avial et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative In Vitro Activities of Torezolid (DA-7157) against Clinical Isolates of Aerobic and Anaerobic Bacteria in South Korea
- (2010) J. H. Yum et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant Staphylococcus aureus Strains Possessing the cfr Methyltransferase Gene or Ribosomal Mutations
- (2010) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Activities of TR-700 (Torezolid) against Staphylococcal Blood Isolates Collected in Spain
- (2010) C. Betriu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Elevated Linezolid Resistance in Clinical cfr-Positive Staphylococcus aureus Isolates Is Associated with Co-Occurring Mutations in Ribosomal Protein L3
- (2010) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Antimicrobial Activities of Torezolid (TR-700), the Active Moiety of a New Oxazolidinone, Torezolid Phosphate (TR-701), Determination of Tentative Disk Diffusion Interpretive Criteria, and Quality Control Ranges
- (2010) S. D. Brown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Lipoglycopeptides
- (2010) George G. Zhanel et al. DRUGS
- Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit
- (2010) Miguel Sánchez García JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial Agent
- (2009) R. Schaadt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)
- (2009) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens
- (2009) R. N. Jones et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci
- (2009) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains
- (2008) K. J. Shaw et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Linezolid for the treatment of drug-resistant infections
- (2008) David J Herrmann et al. Expert Review of Anti-Infective Therapy
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started